Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) rocketted at $20.88, a gain of 25.7%. On Thu, May 26, 2022, ARCT:NASDAQ touched a New 2-Week Intraday Low of $16.54. The stock got featured on our News Catalysts scanner on Fri, May 20, 2022 at 09:11 PM in the 'PRIVATE PLACEMENT' category. From Thu, May 12, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ)
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
Top 10 Gainers:
- Avadel Pharmaceuticals plc (AVDL:NASDAQ), 133.64%
- Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 88.08%
- Allarity Therapeutics Inc. (ALLR:NASDAQ), 39.32%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 38.38%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 34.8%
- Merus N.V. (MRUS:NASDAQ), 32.55%
- Farfetch Limited (FTCH:NYSE), 26.69%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 25.71%
- Grom Social Enterprises Inc. (GROM:NASDAQ), 25.48%
- Icosavax Inc. (ICVX:NASDAQ), 25.37%